Target intelligence / Profile preview

DNA primase large subunit (PRIM2)

Target
PRIM2
Molecular classification
Enzyme, DNA-directed RNA polymerase, DNA replication complex, Primase family
01

Overview

DNA primase large subunit (PRIM2, also known as p58) is an enzyme that forms a heterodimer with a smaller primase subunit (p49), together constituting the primase component of the DNA polymerase alpha-primase complex in eukaryotes[1][4][6]. This complex is essential for chromosomal DNA replication, as it synthesizes short RNA primers that are extended by DNA polymerases to form Okazaki fragments on the lagging strand and initiate leading strand synthesis[1][7]. The 58 kDa large subunit is encoded by the PRIM2 gene in humans and acts as a regulatory and structural partner to the catalytic small subunit during primer formation[1][6][7]. While PRIM2 is fundamental for cell proliferation, there are currently no reported small-molecule drugs or approved inhibitors that specifically target this enzyme in clinical use, and no established biomarker or mechanism-of-action drugs identified from current search results[6][7]. Impairment of PRIM2 function is expected to disrupt DNA replication, which can result in cell cycle arrest or cell death.

Other names
DNA primase subunit 2PRIM2PRIM2Ap58DNA primase 58 kDa subunitprimase (DNA) subunit 2primase, DNA, polypeptide 2 (58kDa)
02

Biological functions

DNA replicationInitiation of DNA synthesisRNA primer synthesis
03

Disease associations

Cancer (by association with DNA replication and cell proliferation)Other (general genomic instability, but no direct disease association established in search results)
04

Safety considerations

Disruption could impair DNA replicationinhibition may impact proliferative tissues

Beyond the preview

Go deeper on DNA primase large subunit (PRIM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA primase large subunit (PRIM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call